Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAFC, formerly known as Sigma-Aldrich Fine Chemicals and now a key brand within the Life Science business of Merck KGaA (operating as MilliporeSigma in the U.S. and Canada), is a leading provider of high-quality raw materials and contract manufacturing services for the biopharmaceutical and pharmaceutical industries. The company specializes in providing critical components for the development and manufacture of complex therapeutics, including cell culture media, highly potent APIs (HPAPIs), and specialized lipids for drug delivery. SAFC offers comprehensive CDMO services that span from clinical development to commercial-scale production, ensuring supply chain transparency and regulatory compliance. Their portfolio is essential for the production of biologics, vaccines, and advanced therapies such as viral vectors and mRNA-based medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAFC Supply Solutions.